Jane Street Group LLC Increases Stake in VanEck Biotech ETF (NASDAQ:BBH)

Jane Street Group LLC lifted its stake in shares of VanEck Biotech ETF (NASDAQ:BBH) by 401.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,348 shares of the company’s stock after buying an additional 6,684 shares during the quarter. Jane Street Group LLC’s holdings in VanEck Biotech ETF were worth $1,481,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in BBH. Northwestern Mutual Wealth Management Co. grew its stake in shares of VanEck Biotech ETF by 5.8% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 24,324 shares of the company’s stock worth $4,096,000 after purchasing an additional 1,334 shares in the last quarter. Truist Financial Corp raised its stake in VanEck Biotech ETF by 3.8% in the second quarter. Truist Financial Corp now owns 2,703 shares of the company’s stock valued at $455,000 after buying an additional 100 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in VanEck Biotech ETF by 10,376,390.9% during the 3rd quarter. International Assets Investment Management LLC now owns 1,141,414 shares of the company’s stock worth $202,475,000 after buying an additional 1,141,403 shares during the last quarter. Tyler Stone Wealth Management boosted its position in shares of VanEck Biotech ETF by 79.5% during the 3rd quarter. Tyler Stone Wealth Management now owns 1,472 shares of the company’s stock worth $261,000 after acquiring an additional 652 shares in the last quarter. Finally, Coastline Trust Co purchased a new position in shares of VanEck Biotech ETF in the 3rd quarter valued at about $59,000. 32.05% of the stock is currently owned by hedge funds and other institutional investors.

VanEck Biotech ETF Price Performance

Shares of NASDAQ BBH opened at $158.24 on Friday. The stock’s 50-day simple moving average is $166.60 and its 200-day simple moving average is $172.53. VanEck Biotech ETF has a fifty-two week low of $151.35 and a fifty-two week high of $183.64.

VanEck Biotech ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were issued a dividend of $1.2517 per share. The ex-dividend date was Monday, December 23rd.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.